Back to search

Article

Immunity to SARS-CoV-2 in a Dialyzed Patient Who Developed COVID-19 Twenty Days After the Second Dose of BNT162b2 Vaccine: a Case Report

2021-07-21

Abstract excerpt

<title>Abstract</title> <p>IntroductionEnd stage kidney disease (ESKD) and cancer have been identified as risk factors for severe and fatal cases of COVID-19, making vaccination in these patients a priority. Patients suffering from ESKD have a significantly weaker response to common vaccines than general population. However, humoral and cellular immune responses after two doses of RNA-based vaccine BNT162b2 (Pfiz...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ebfe2cab-c5af-5cb1-ad6c-3528a1546723
DOI
10.21203/rs.3.rs-711429/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Immunity to SARS-CoV-2 in a Dialyzed Patient Who Developed COVID-19 Twenty Days After the Second Dose of BNT162b2 Vaccine: a Case ReportDOI 10.21203/rs.3.rs-711429/v1
Select a neighboring publication to make it the new centre.